Citeline Podcasts

This week Gray Sheet reporters and editors discuss our analysis of 2014 Medical Device recalls, St. Jude's U.S. Portico transcatheter aortic valve trial, an upcoming FDA guidance to address criteria for whether an advisory panel needs to be called, our recently launched FDA Decision Data tables, reactions on how the 21st Century Cures bill provision on advisory panels will change their membership, ongoing work to converge U.S. and Canadian device regulations, and a lot more. Read more at www.thegraysheet.com/a/01150608015

This week Gray Sheet reporters and editors discuss our analysis of 2014 Medical Device recalls, St. Jude's U.S. Portico transcatheter aortic valve trial, an upcoming FDA guidance to address criteria for whether an advisory panel needs to be called, our recently launched FDA Decision Data tables, reactions on how the 21st Century Cures bill provision on advisory panels will change their membership, ongoing work to converge U.S. and Canadian device regulations, and a lot more. Read more at www.thegraysheet.com/a/01150608015

With many cosmetic companies choosing to phase out use of traditional preservatives due to pressure from retailers and NGOs, formulators are resorting to alternatives that may not be as effective, among other drawbacks. Cosmetic chemist, author and blogger Perry Romanowski questioned the trend in an interview with "The Rose Sheet," suggesting that while standing by traditional preservatives can be bad for PR in the short term, most consumers' purchasing decisions tend not to be affected. Read more at: www.therosesheet.com/a/02150608003

With many cosmetic companies choosing to phase out use of traditional preservatives due to pressure from retailers and NGOs, formulators are resorting to alternatives that may not be as effective, among other drawbacks. Cosmetic chemist, author and blogger Perry Romanowski questioned the trend in an interview with "The Rose Sheet," suggesting that while standing by traditional preservatives can be bad for PR in the short term, most consumers' purchasing decisions tend not to be affected. Read more at: www.therosesheet.com/a/02150608003

The cosmetic sector’s shrinking preservative palette calls for a dramatic marketing shift, according to industry veteran David Steinberg of Steinberg & Associates. In a May 11 interview, the cosmetic chemistry expert discussed movement away from proven preservative systems, implications for industry and consumer safety and options for manufacturers intent on eschewing traditional preservatives, which are few and expensive. Read the full article here: http://www.therosesheet.com/a/02150601003

The cosmetic sector’s shrinking preservative palette calls for a dramatic marketing shift, according to industry veteran David Steinberg of Steinberg & Associates. In a May 11 interview, the cosmetic chemistry expert discussed movement away from proven preservative systems, implications for industry and consumer safety and options for manufacturers intent on eschewing traditional preservatives, which are few and expensive. Read the full article here: http://www.therosesheet.com/a/02150601003

The Medical Device Innovation Consortium has released a report on how industry and FDA can take patient risk-benefit preferences into consideration when developing and approving new devices. Bill Murray, the organization's CEO spoke to the Gray Sheet about their findings and recommendations. Read the full article here: http://www.thegraysheet.com/a/01150518006

The Medical Device Innovation Consortium has released a report on how industry and FDA can take patient risk-benefit preferences into consideration when developing and approving new devices. Bill Murray, the organization's CEO spoke to the Gray Sheet about their findings and recommendations. Read the full article here: http://www.thegraysheet.com/a/01150518006

As more and more people with medical implants face situations requiring magnetic resonance scans, FDA has partnered with the Med Institute to spend the next three years trying to understand what standards could be used to determine whether a device is MR compatible. Read more at: https://www.thegraysheet.com/a/01150504019

As more and more people with medical implants face situations requiring magnetic resonance scans, FDA has partnered with the Med Institute to spend the next three years trying to understand what standards could be used to determine whether a device is MR compatible. Read more at: https://www.thegraysheet.com/a/01150504019